scholarly article | Q13442814 |
P356 | DOI | 10.3920/BM2012.0008 |
P953 | full work available at URL | https://brill.com/view/journals/bm/3/2/article-p85_85.xml |
https://www.wageningenacademic.com/doi/pdf/10.3920/BM2012.0008?download=true | ||
P698 | PubMed publication ID | 22683835 |
P2093 | author name string | M. B. Katan | |
P2860 | cites work | Nederlands Tijdschrift voor Geneeskunde | Q1891153 |
World Journal of Gastroenterology | Q15708885 | ||
Relationship between funding source and conclusion among nutrition-related scientific articles | Q21092377 | ||
Why most published research findings are false | Q21092395 | ||
Probiotics for preventing acute upper respiratory tract infections | Q24234353 | ||
Probiotics for the prevention of pediatric antibiotic-associated diarrhea | Q24235039 | ||
Probiotics for treating acute infectious diarrhoea | Q24236704 | ||
Current level of consensus on probiotic science--report of an expert meeting--London, 23 November 2009 | Q24601092 | ||
26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: evidence-based nutrition | Q34195023 | ||
The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review | Q34989914 | ||
Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials | Q37361239 | ||
Industry-sponsored clinical research: a broken system | Q45290782 | ||
Guidance on the scientific requirements for health claims related to gut and immune function | Q47149591 | ||
Unresolved questions concerning etiology of Alzheimer’s disease: Hypometabolism | Q53416559 | ||
Opinion paper: Quo vadis - EFSA? | Q85070525 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | food safety | Q909821 |
probiotics | Q1816730 | ||
P304 | page(s) | 85-89 | |
P577 | publication date | 2012-06-01 | |
P1433 | published in | Beneficial microbes | Q27722361 |
P1476 | title | Why the European Food Safety Authority was right to reject health claims for probiotics | |
P478 | volume | 3 |
Q38427654 | A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union |
Q49420341 | From Diabetes Care to Diabetes Cure-The Integration of Systems Biology, eHealth, and Behavioral Change |
Q38582214 | Functional foods as potential therapeutic options for metabolic syndrome. |
Q33682584 | Impact of emergency department probiotic treatment of pediatric gastroenteritis: study protocol for the PROGUT (Probiotic Regimen for Outpatient Gastroenteritis Utility of Treatment) randomized controlled trial |
Q36078523 | Isolation and characterization of bacteriocinogenic lactic bacteria from M-Tuba and Tepache, two traditional fermented beverages in México |
Q38070061 | Mobilome and genetic modification of bifidobacteria. |
Q97094546 | Molecular and in vitro assessment of some probiotic characteristics of amylolytic Lactobacillus plantarum strains from Bulgarian fermented products |
Q48924009 | Probiotics and antimicrobial peptides: the creatures' and substances' future in the twenty-first century: an opinion letter. |
Q86153118 | Probiotics in gastroenterology -- from a different angle |
Q64987549 | Probiotics: If It Does Not Help It Does Not Do Any Harm. Really? |
Q42040216 | Randomised controlled trial of Lactobacillus rhamnosus (LGG) versus placebo in children presenting to the emergency department with acute gastroenteritis: the PECARN probiotic study protocol |
Q28656379 | Related actions of probiotics and antibiotics on gut microbiota and weight modification |
Q35800667 | Scientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges. |
Q34746651 | Synergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury |
Q31155214 | The future of yogurt: scientific and regulatory needs |
Q34144918 | Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review |
Search more.